Trial Profile
Characteristics and Health Outcomes of Patients With Type 2 Diabetes Treated With Canagliflozin Added to Insulin Therapy in a Real-world Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Jun 2017 Results (n=265) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 09 Sep 2016 Status changed from not yet recruiting to completed.
- 22 Feb 2016 New trial record